HomeCompareSPDV vs JNJ

SPDV vs JNJ: Dividend Comparison 2026

SPDV yields 3.23% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPDV wins by $4.6K in total portfolio value
10 years
SPDV
SPDV
● Live price
3.23%
Share price
$37.23
Annual div
$1.20
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$398.20
Full SPDV calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SPDV vs JNJ

📍 SPDV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPDVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPDV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPDV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPDV
Annual income on $10K today (after 15% tax)
$274.86/yr
After 10yr DRIP, annual income (after tax)
$338.47/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $365.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPDV + JNJ for your $10,000?

SPDV: 50%JNJ: 50%
100% JNJ50/50100% SPDV
Portfolio after 10yr
$22.3K
Annual income
$612.99/yr
Blended yield
2.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPDV
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPDV buys
0
JNJ buys
0
No recent congressional trades found for SPDV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPDVJNJ
Forward yield3.23%3.36%
Annual dividend / share$1.20$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.6K$20.0K
Annual income after 10y$398.20$827.78
Total dividends collected$3.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPDV vs JNJ ($10,000, DRIP)

YearSPDV PortfolioSPDV Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,023$323.37$10,676$355.77+$347.00SPDV
2$12,128$333.14$11,407$389.39+$721.00SPDV
3$13,320$342.55$12,198$426.53+$1.1KSPDV
4$14,604$351.59$13,056$467.62+$1.5KSPDV
5$15,986$360.26$13,987$513.12+$2.0KSPDV
6$17,474$368.57$14,998$563.56+$2.5KSPDV
7$19,073$376.51$16,098$619.52+$3.0KSPDV
8$20,793$384.09$17,295$681.69+$3.5KSPDV
9$22,639$391.32$18,599$750.82+$4.0KSPDV
10$24,622$398.20$20,022$827.78+$4.6KSPDV

SPDV vs JNJ: Complete Analysis 2026

SPDVStock

The index is a rules-based, equal-weighted index that is designed to provide exposure to the constituents of the S&P 500 Index that exhibit both high dividend yield and sustainable dividend distribution characteristics, while maintaining diversified sector exposure. At least 80% of the fund’s net assets, plus borrowings for investment purposes, will be invested in equity securities that (i) are included in the S&P 500 Index and (ii) have had a positive indicated annual dividend yield within the past year.

Full SPDV Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SPDV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPDV vs SCHDSPDV vs JEPISPDV vs OSPDV vs KOSPDV vs MAINSPDV vs ABBVSPDV vs MRKSPDV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.